Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver - Contacts and Locations

Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver

This study is ongoing, but not recruiting participants.

Study NCT00030563. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00030563

Locations


United States, Ohio
	Ireland Cancer Center
	Cleveland, Ohio, United States, 44106-5065

United States, Washington
	University of Washington School of Medicine
	Seattle, Washington, United States, 98195

Canada, Ontario
	Princess Margaret Hospital
	Toronto, Ontario, Canada, M5G 2M9

Sponsors and Collaborators

University of Washington

National Cancer Institute (NCI)

Investigators


Study Chair:	Kevin G. Billingsley, MD	University of Washington